Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Piotroski F-Score: 6 (As of Jul. 21, 2026) — 20% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688117 Cheng Du Sheng Nuo Biotec Co Ltd SHSE:688117
84 GF Score
Price ¥24.55
GF Value ¥28.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Cheng Du Sheng Nuo Biotec Co Piotroski F-Score?

Cheng Du Sheng Nuo Biotec Co SHSE:688117 -0.41% 84 Piotroski F-Score is 6 as of Jul. 21, 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates SHSE:688117 with a GF Score™ of 84/100 and a GF Value™ of ¥28.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 979 Drug Manufacturers companies, Cheng Du Sheng Nuo Biotec Co ranks better than 78.96% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cheng Du Sheng Nuo Biotec Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score or its related term are showing as below:

SHSE:688117' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 6

During the past 9 years, the highest Piotroski F-Score of Cheng Du Sheng Nuo Biotec Co was 8. The lowest was 3. And the median was 5.

Cheng Du Sheng Nuo Biotec Co  (SHSE:688117) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cheng Du Sheng Nuo Biotec Co Piotroski F-Score Related Terms


Cheng Du Sheng Nuo Biotec Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cheng Du Sheng Nuo Biotec Co Piotroski F-Score Chart

Cheng Du Sheng Nuo Biotec Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 3.00 4.00 3.00 4.00 7.00

Cheng Du Sheng Nuo Biotec Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 7.00 6.00

SHSE:688117 vs ZTS, UTHR: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cheng Du Sheng Nuo Biotec Co Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score falls into.


SHSE:688117
84GF Score
Cheng Du Sheng Nuo Biotec Co Ltd SHSE:688117
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 41.837 + 38.053 + 30.914 + 66.362 = ¥177.2 Mil.
Cash Flow from Operations was 72.897 + -21.556 + 118.344 + -22.124 = ¥147.6 Mil.
Revenue was 153.233 + 182.547 + 221.338 + 244.285 = ¥801.4 Mil.
Gross Profit was 88.613 + 102.717 + 132.738 + 146.249 = ¥470.3 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1664.893 + 1755.995 + 1909.147 + 1934.528 + 2008.447) / 5 = ¥1854.602 Mil.
Total Assets at the begining of this year (Mar25) was ¥1,664.9 Mil.
Long-Term Debt & Capital Lease Obligation was ¥316.1 Mil.
Total Current Assets was ¥948.1 Mil.
Total Current Liabilities was ¥446.8 Mil.
Net Income was 5.315 + 35.159 + -6.923 + 47.12 = ¥80.7 Mil.

Revenue was 94.88 + 138.898 + 118.234 + 184.337 = ¥536.3 Mil.
Gross Profit was 52.851 + 80.762 + 65.069 + 103.417 = ¥302.1 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1354.784 + 1462.35 + 1528.053 + 1647.901 + 1664.893) / 5 = ¥1531.5962 Mil.
Total Assets at the begining of last year (Mar24) was ¥1,354.8 Mil.
Long-Term Debt & Capital Lease Obligation was ¥96.9 Mil.
Total Current Assets was ¥708.1 Mil.
Total Current Liabilities was ¥582.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cheng Du Sheng Nuo Biotec Co's current Net Income (TTM) was 177.2. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cheng Du Sheng Nuo Biotec Co's current Cash Flow from Operations (TTM) was 147.6. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=177.166/1664.893
=0.10641284

ROA (Last Year)=Net Income/Total Assets (Mar24)
=80.671/1354.784
=0.05954529

Cheng Du Sheng Nuo Biotec Co's return on assets of this year was 0.10641284. Cheng Du Sheng Nuo Biotec Co's return on assets of last year was 0.05954529. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cheng Du Sheng Nuo Biotec Co's current Net Income (TTM) was 177.2. Cheng Du Sheng Nuo Biotec Co's current Cash Flow from Operations (TTM) was 147.6. ==> 147.6 <= 177.2 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=316.136/1854.602
=0.17046029

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=96.94/1531.5962
=0.06329345

Cheng Du Sheng Nuo Biotec Co's gearing of this year was 0.17046029. Cheng Du Sheng Nuo Biotec Co's gearing of last year was 0.06329345. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=948.07/446.757
=2.1221156

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=708.094/582.109
=1.21642854

Cheng Du Sheng Nuo Biotec Co's current ratio of this year was 2.1221156. Cheng Du Sheng Nuo Biotec Co's current ratio of last year was 1.21642854. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cheng Du Sheng Nuo Biotec Co's number of shares in issue this year was 221.207. Cheng Du Sheng Nuo Biotec Co's number of shares in issue last year was 219.892. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=470.317/801.403
=0.58686703

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=302.099/536.349
=0.56325079

Cheng Du Sheng Nuo Biotec Co's gross margin of this year was 0.58686703. Cheng Du Sheng Nuo Biotec Co's gross margin of last year was 0.56325079. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=801.403/1664.893
=0.48135406

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=536.349/1354.784
=0.39589263

Cheng Du Sheng Nuo Biotec Co's asset turnover of this year was 0.48135406. Cheng Du Sheng Nuo Biotec Co's asset turnover of last year was 0.39589263. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+0+1+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cheng Du Sheng Nuo Biotec Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Cheng Du Sheng Nuo Biotec Co (SHSE:688117) has a Piotroski F-Score of 6 as of Jul. 21, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cheng Du Sheng Nuo Biotec Co and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #206 out of 979 companies in the Drug Manufacturers industry, placing it in the top 21%.
Is Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score too high?
Cheng Du Sheng Nuo Biotec Co's current Piotroski F-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Cheng Du Sheng Nuo Biotec Co's value of 6 is 20% above this industry median. Based on the distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #206 out of 979 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Cheng Du Sheng Nuo Biotec Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cheng Du Sheng Nuo Biotec Co's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #206 out of 979 companies for Piotroski F-Score. This places Cheng Du Sheng Nuo Biotec Co in the top 21% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Cheng Du Sheng Nuo Biotec Co's value of 6 is 20% above this benchmark. Historically, Cheng Du Sheng Nuo Biotec Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Cheng Du Sheng Nuo Biotec Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 979 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cheng Du Sheng Nuo Biotec Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Cheng Du Sheng Nuo Biotec Co and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cheng Du Sheng Nuo Biotec Co's current Piotroski F-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheng Du Sheng Nuo Biotec Co stock overvalued right now?
Based on GuruFocus' analysis, Cheng Du Sheng Nuo Biotec Co (SHSE:688117) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.89, compared to a current price of ¥24.55 — trading 15% below its estimated fair value. The current Piotroski F-Score is 6, which is 20% above median its 10-year median of 5.00 and 20% above the Drug Manufacturers industry median of 5.00. Cheng Du Sheng Nuo Biotec Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Cheng Du Sheng Nuo Biotec Co (SHSE:688117), the current Piotroski F-Score is 6 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Overvalued in 2026?

Based on GuruFocus' analysis, Cheng Du Sheng Nuo Biotec Co stock appears to be undervalued. The current stock price of ¥24.55 is trading 15% below its estimated GF Value™ of ¥28.89. GuruFocus considers Cheng Du Sheng Nuo Biotec Co to be Modestly Undervalued.

Key valuation signals for SHSE:688117:

  • Piotroski F-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: ¥28.89 vs. price of ¥24.55 (15% below fair value)
  • GF Score™: 84/100 with 3 warning signs
  • Industry Position: 20% above the Drug Manufacturers median (#206 of 979)

No single metric tells the full story. See the SHSE:688117 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cheng Du Sheng Nuo Biotec Co Business Description

Address Section 1, Gongye Avenue, Jinyuan Town, Dayi County, Sichuan Province, Chengdu, CHN, 611330
Cheng Du Sheng Nuo Biotec Co Ltd is a independent research and development, production and sales of peptide raw materials and preparation products.
84GF Score

Get the complete analysis for SHSE:688117

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.55
Price
¥28.89
GF Value